Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii ANTIBIOTICS 2022
Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022
Long-term subjective and objective assessment of smell and taste in COVID-19 CELLS 2022
Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19 MICROORGANISMS 2022
Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY 2022
Development of a clinical risk score to predict death in patients with COVID-19 DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity EUROPEAN JOURNAL OF IMMUNOLOGY 2022
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2022
Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients FRONTIERS IN IMMUNOLOGY 2022
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 SCIENTIFIC REPORTS 2022
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19 JOURNAL OF CLINICAL MEDICINE 2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature NEW MICROBIOLOGICA 2022
The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2022
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis CLINICAL RHEUMATOLOGY 2022
THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2 THROMBOSIS AND HAEMOSTASIS 2022
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study LE INFEZIONI IN MEDICINA 2022
COVID-19 Severity and Androgen Receptor Polymorphism BIOLOGY 2022
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared ANTIBIOTICS 2022
Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Post-Traumatic Stress Disorder Trajectories the Year after COVID-19 Hospitalization INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma